Khonsu Therapeutics' Seed Round

Khonsu Therapeutics raised a round of funding on June 16, 2017. Investors include RebelBio.

Khonsu Therapeutics is developing therapeutic proteins for autoimmune and inflammatory indications in human and animal health.…

Articles about Khonsu Therapeutics' Seed Round: